Outcomes of surgery for high transsphincteric anal fistulas: prospective randomized trial

Q4 Immunology and Microbiology
Y. Churina, D. Shlyk, R. Rzayev, V. Balaban, P. Tsarkov
{"title":"Outcomes of surgery for high transsphincteric anal fistulas: prospective randomized trial","authors":"Y. Churina, D. Shlyk, R. Rzayev, V. Balaban, P. Tsarkov","doi":"10.29413/abs.2023-8.3.21","DOIUrl":null,"url":null,"abstract":"Background. Reliable data on the efficacy and safety of fistulectomy with primary sphincter repair for the treatment of high transsphincteric anal fistulas are deficient.The aim. To compare the efficacy and safety of fistulectomy with advancement muco-muscular flap (F) and fistulectomy with primary sphincter reconstruction (SR) for the treatment of high anorectal fistulas.Methods. A cohort of 92 consecutive patients with transsphincteric anal fistula involving 1/3 to 2/3 of the sphincteric complex were included in prospective randomized study. The primary endpoint was the recurrence rate. The duration of surgery, blood loss, pain intensity, postoperative complications, the duration of wound healing, incontinence, quality of life were registered.Results. Forty-six patients were randomized in each group. A statistically significant difference was obtained for operative time (Group “F” – 45 (20–160) min, Group “SR” – 33 (10–55) min). The blood loss was 3 (1–20) and 2 (1–10) ml in Groups “F” and “SR”, respectively (p = 0.482). The return to work in Groups “SR” and “F” occurred after 7 (2–14) and 8 (4–20) days, respectively (p = 0.005). The pain syndrome was significantly greater in Group “F” (p < 0.05) on days 1 and 7. Recurrence rate was in 23.9 % (11 cases) in Group “F” and in 6.5 % (3 cases) in Group “SR” (p = 0.042). Incontinence was in 7 (15.2 %) people in Group “F”, in 10 patients (21.7 %) – in Group “SR” (p = 0.591). There was no statistically significant difference in postoperative complications.Conclusion. Findings can expand the indications for the treatment of high transsphincteric anorectal fistulas involving from 1/3 to 2/3 of the sphincter complex without statistically significant risk for functional results.","PeriodicalId":32463,"journal":{"name":"Acta Biomedica Scientifica","volume":"23 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Biomedica Scientifica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29413/abs.2023-8.3.21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 0

Abstract

Background. Reliable data on the efficacy and safety of fistulectomy with primary sphincter repair for the treatment of high transsphincteric anal fistulas are deficient.The aim. To compare the efficacy and safety of fistulectomy with advancement muco-muscular flap (F) and fistulectomy with primary sphincter reconstruction (SR) for the treatment of high anorectal fistulas.Methods. A cohort of 92 consecutive patients with transsphincteric anal fistula involving 1/3 to 2/3 of the sphincteric complex were included in prospective randomized study. The primary endpoint was the recurrence rate. The duration of surgery, blood loss, pain intensity, postoperative complications, the duration of wound healing, incontinence, quality of life were registered.Results. Forty-six patients were randomized in each group. A statistically significant difference was obtained for operative time (Group “F” – 45 (20–160) min, Group “SR” – 33 (10–55) min). The blood loss was 3 (1–20) and 2 (1–10) ml in Groups “F” and “SR”, respectively (p = 0.482). The return to work in Groups “SR” and “F” occurred after 7 (2–14) and 8 (4–20) days, respectively (p = 0.005). The pain syndrome was significantly greater in Group “F” (p < 0.05) on days 1 and 7. Recurrence rate was in 23.9 % (11 cases) in Group “F” and in 6.5 % (3 cases) in Group “SR” (p = 0.042). Incontinence was in 7 (15.2 %) people in Group “F”, in 10 patients (21.7 %) – in Group “SR” (p = 0.591). There was no statistically significant difference in postoperative complications.Conclusion. Findings can expand the indications for the treatment of high transsphincteric anorectal fistulas involving from 1/3 to 2/3 of the sphincter complex without statistically significant risk for functional results.
高位经括约肌肛瘘手术治疗的结果:前瞻性随机试验
背景。关于瘘管切除术联合初级括约肌修复治疗高位经括约肌肛瘘的有效性和安全性的可靠数据缺乏。的目标。目的:比较先进的粘膜肌肉瓣造瘘术(F)与一期括约肌重建造瘘术(SR)治疗高位肛肠瘘的疗效和安全性。前瞻性随机研究纳入92例连续经括约肌肛瘘患者,其中1/3 ~ 2/3为括约肌复合体。主要终点是复发率。记录手术时间、出血量、疼痛强度、术后并发症、伤口愈合时间、尿失禁、生活质量。每组随机选取46例患者。手术时间F组- 45 (20-160)min, SR组- 33 (10-55)min,差异有统计学意义。F组出血量为3 (1 ~ 20)ml, SR组出血量为2 (1 ~ 10)ml (p = 0.482)。“SR”组和“F”组分别在7(2-14)天和8(4-20)天后恢复工作(p = 0.005)。F组疼痛症状在第1、7天明显加重(p < 0.05)。F组复发率为23.9%(11例),SR组复发率为6.5%(3例)(p = 0.042)。“F”组尿失禁7例(15.2%),“SR”组尿失禁10例(21.7%)(p = 0.591)。两组术后并发症比较,差异无统计学意义。研究结果可以扩大高位经括约肌直肠肛瘘的适应症,累及约1/3至2/3的括约肌复合体,对功能结果无统计学意义的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Biomedica Scientifica
Acta Biomedica Scientifica Immunology and Microbiology-General Immunology and Microbiology
CiteScore
0.40
自引率
0.00%
发文量
106
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信